top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

In Vitro Diagnostics Market: Pin-Point Analysis for Changing Competitive Dynamics

0 votes
4 views

The global in-vitro diagnostics market is predicted to experience brisk development in the coming years, according to a Transparency Market Research (TMR) report. The in-vitro diagnostics market comprises of a highly competitive business landscape, with a large pool of vendors across the globe. Players in the global in-vitro diagnostics market are keen on focusing on research and development of innovative products. This is a key activity adopted by vendors in order to gain a brand presence in the global in-vitro diagnostics market.

Another key strategy being adopted by vendors in the global in-vitro diagnostics tests engaging in mergers and acquisitions. This is expected to aid vendors in penetrating the global market. A good instance, is the joint agreement between Sysmex Corporation and JVCKENWOOD Corporation to establish a new enterprise Creative Nanosystems Corporation. Instances like these are expected to open new avenues in the global in-vitro diagnostics market in the coming years.

Planning To Lay Down Future Strategy? Request Brochure Of In Vitro Diagnostics Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1395

TMR analysts report that the global in-vitro diagnostics market, which was worth US$55000 mn in 2016, is likely to reach a value of S$89862.2 mn by the end of 2025. The market is forecasted to rise at a 5.6% CAGR over the forecast period of 2017 to 2025.

The segment of clinical chemistry is projected to gain significant traction in the coming years. The technology held over 25% share in the global in-vitro diagnostics market in 2016. Regionally, North America is expected to account for significant revenue in the market over the forecast period. This could be due to the well-established healthcare infrastructure in the region.

Rise in Prevalence of Chronic Ailments to Drive Growth

In 2017 it was estimated that around 23.5 million Americans were living with autoimmune diseases, the National Health Institute (NIH) said. During the forecast period, the prevalence is expected to increase. In 2018, an estimated 1.7 million new cancer cases are reported and approximately 609,640 people are likely to death from cancer, the American Cancer Society (ACS reports). Regular diagnostic testing is needed for the growing geriatric population that is prone to disease. This is one of the key drivers of market growth.

In addition, it is estimated, in terms of accuracy, portability and cost effectiveness, that technological developments will accelerate demand for IVD devices. Improved technologies such as micro-fluid miniaturization, biochips, and nano-biotechnology should help boost the demand for PoC products. Such improvements have resulted in increased access to points of diagnosis testing and the results of the tests are expected to be fast and effective.

To Obtain All-Inclusive Information On Forecast Analysis Of In Vitro Diagnostics Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1395

Preference for Minimally Invasive Surgeries to Boost Opportunity

Demand in the global in-vitro diagnostic market for non-invasive or minimally invasive processes brings new horizons. In addition, some of the other factors that support market growth are further developments in monitoring treatment and increased accessibility of over – the-counter tests. Early-stage demand for the treatment of a disease helps the market to develop traction. The fact that clinical laboratories are not needed in the tests is another reason behind the popularity of the in vitro diagnostic market. Pregnancy testing is now done with a test kit in a safe manner. As it a safe and convenient way, this is fuelling the global in-vitro diagnostics tests market.

A key factor that may hamper the in-vitro diagnostics market is the complexity involved in reimbursement of the tests. This could deter the market growth to some extent.

posted Feb 11 by Rohini Chaudhari

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. To reduce effects of such hindrances, the new entrants are focusing on schemes such as mergers,  collaborations, and partnerships. These strategies provide necessary resources to the new players so that they can have a sustainable future in the global autoimmune disease diagnostics market.

On the other hand, the established players are focusing on strategies such as innovative product launches, intense research and developments, and various other steps in order to maintain their dominance in the global autoimmune disease diagnostics market. A few of the players are also adopting strategies like acquisition of various small and medium-scale businesses in order to expand their resource bank and brand presence across regional markets of the world.

Request Sample @

 https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351

According to the report, the global autoimmune disease diagnostics market is projected to exhibit a moderate growth with 3.8% CAGR in the forecast period of 2015 to 2023. Moreover, the global autoimmune disease diagnostics market is projected to reach the value of US$17.06 bn by the end of 2023.

  • Increasing Elderly Population to Boost the Growth of Rheumatoid Arthritis Segment

The global autoimmune disease diagnostics market is segmented on the basis of disease type, test type, and region. Out of these categories, rheumatoid arthritis segment under disease type category is expected to exhibit maximum growth in the global autoimmune disease diagnostics market. The growth of the segment is attributed to parameters such as rising number of aging population and enhanced diagnostic services.

  • North America is likely to Show Maximum Potential during the Forecast

Geographically, the global autoimmune disease diagnostics market has its presence in region of North America, South America, Europe, Asia Pacific, and Middle East and Africa. Out of these regions, North America is expected to showcase high scope for players in the market. The growth of the region is attributed to the presence of majority of major players and novel developments in healthcare sector in North America.

Rising Investment in Healthcare Sector to Boost the Growth of the Market

  • Growing Healthcare Expenditure to Promote the Growth of Market

As a result of growing economy of various regions, there is a substantial growth in disposable income of the people. This allows them to invest significantly in their healthcare expenditure especially in autoimmune treatments. This in turn is supporting the growth of global autoimmune disease diagnostics market in the forecast period.

  • Supporting Government Initiatives to Help the Growth of the Market

Growing support from governments of various countries and various government initiatives to widespread the awareness of autoimmune diseases is one of the most prominent factors that is supporting the growth of global autoimmune disease diagnostics market.

Despite of Numerous Growth Factors, Market is Expected to Face Many Challenges

  • Shortcoming of Professional Operatives to Dampen the Growth of the Market

The growth of autoimmune disease diagnostics market is supported by various parameters. However, there are some tough challenges in the road to success for players in the market. One of the major challenges that players might have to deal with is the unavailability of skilled professionals who can do precise diagnosis of the disease. This may lead to an error filled result impacting drastically on the health of the patient. Due to this reason, the growth of global autoimmune disease market is likely to get hamper in the forecast period.

  • Various New Markets in the Emerging Economies Are Offering Better Opportunities

There are several challenges that are expected to hamper the growth of global autoimmune disease diagnostics market in the forecast period. However, factors such as new emerging economies, innovative product launches by various players, and intense research and development to replace conventional treatment for autoimmune diseases are likely to support the global autoimmune disease diagnostics market. In this way the challenges could be overcome up to a certain extent.

0 votes

The global in-vitro diagnostics market is predicted to experience brisk development in the coming years, according to a Transparency Market Research (TMR) report. The in-vitro diagnostics market comprises of a highly competitive business landscape, with a large pool of vendors across the globe. Players in the global in-vitro diagnostics market are keen on focusing on research and development of innovative products. This is a key activity adopted by vendors in order to gain a brand presence in the global in-vitro diagnostics market.

Another key strategy being adopted by vendors in the global in-vitro diagnostics tests engaging in mergers and acquisitions. This is expected to aid vendors in penetrating the global market. A good instance, is the joint agreement between Sysmex Corporation and JVCKENWOOD Corporation to establish a new enterprise Creative Nanosystems Corporation. Instances like these are expected to open new avenues in the global in-vitro diagnostics market in the coming years.

TMR analysts report that the global in-vitro diagnostics market, which was worth US$55000 mn in 2016, is likely to reach a value of S$89862.2 mn by the end of 2025. The market is forecasted to rise at a 5.6% CAGR over the forecast period of 2017 to 2025.

The segment of clinical chemistry is projected to gain significant traction in the coming years. The technology held over 25% share in the global in-vitro diagnostics market in 2016. Regionally, North America is expected to account for significant revenue in the market over the forecast period. This could be due to the well-established healthcare infrastructure in the region.

Request Sample @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1395

Rise in Prevalence of Chronic Ailments to Drive Growth

In 2017 it was estimated that around 23.5 million Americans were living with autoimmune diseases, the National Health Institute (NIH) said. During the forecast period, the prevalence is expected to increase. In 2018, an estimated 1.7 million new cancer cases are reported and approximately 609,640 people are likely to death from cancer, the American Cancer Society (ACS reports). Regular diagnostic testing is needed for the growing geriatric population that is prone to disease. This is one of the key drivers of market growth.

In addition, it is estimated, in terms of accuracy, portability and cost effectiveness, that technological developments will accelerate demand for IVD devices. Improved technologies such as micro-fluid miniaturization, biochips, and nano-biotechnology should help boost the demand for PoC products. Such improvements have resulted in increased access to points of diagnosis testing and the results of the tests are expected to be fast and effective.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1395

Preference for Minimally Invasive Surgeries to Boost Opportunity

Demand in the global in-vitro diagnostic market for non-invasive or minimally invasive processes brings new horizons. In addition, some of the other factors that support market growth are further developments in monitoring treatment and increased accessibility of over – the-counter tests. Early-stage demand for the treatment of a disease helps the market to develop traction. The fact that clinical laboratories are not needed in the tests is another reason behind the popularity of the in vitro diagnostic market. Pregnancy testing is now done with a test kit in a safe manner. As it a safe and convenient way, this is fuelling the global in-vitro diagnostics tests market.

A key factor that may hamper the in-vitro diagnostics market is the complexity involved in reimbursement of the tests. This could deter the market growth to some extent.

0 votes

Some of the prominent participants in the global computed tomography (CT) market are GE Healthcare, Siemens Healthineers, Hitachi Medical Systems, Philips Healthcare, Neusoft Medical Systems, Toshiba Medical, Samsung Medison, Neurologica Corporation, DxRay Inc., MARS Bioimaging Inc., LL Tech Inc., and Koning Corporation. These deep pocketed players have been pouring money into cutting edge research and development to come up with more evolved products. They are also always on the lookout for strategic mergers and acquisitions and partnerships in order to tap into synergies.

A recent report on the market for computed tomography (CT) published by Transparency Market Research finds that the market’s worth was around US$5.6 billion in 2017. It also finds that it has grown incrementally in the past few years and going forward too will continue to rise steadily.

Depending upon the type of computed tomography (CT) available in the market, the high end slice CT has been grossing considerable revenues. As per our report, its revenue share in the market in 2017 was around 55.9%. From a geographic standpoint, North America leads the market with a dominant share. This is because of the superior healthcare facilities in the region which are equipped with latest high-end CT devices. This is mainly because of the greater healthcare spends among people and also because of greater government support for healthcare institutions.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=227

Growing Cases of Cancer Worldwide Fuels Uptake of Computed Tomography (CT) Devices

Computed tomography (CT), which is basically digitalized X-ray imaging procedure for diagnosing bones, internal organs, blood vessels, and soft tissue, and blood vessels, is highly useful in uncovering various types of cancer tumors. At the forefront of driving their sales is the rising instances of cancer worldwide on account of lifestyle changes. As per WHO, nearly 8.8 million people worldwide succumbed to cancer in 2015. However, 30% to 50% of cancer can be prevented with early diagnosis and rising awareness about this is expected to majorly stoke adoption of computed tomography which can enable physicians to not just uncover a tumor but also gauge its location and size.

Overall, the global CT market has majorly benefitted from the growing preference of minimally invasive diagnostic procedures. Explains the lead analyst of the report, “Primarily fuelling the market is the growing shift towards image guided interventions in the domain of medical care, alongside the continued technological improvement in image processing and resolution. As a result, computed tomography is finding application in detecting various cardiovascular, neurovascular, abdomen and pelvic, pulmonary, spinal, and musculoskeletal issues.”

Buy Now This Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=227&ltype=S

Increasing Spending Capacity of People Coupled with Declining Device Prices Promote Market

Another factor promoting the market is the increasing spending capacity of people worldwide owing to economic development and rising knowledge about preventing numerous chronic health conditions through early diagnosis. This, coupled with declining prices of devices is expected to catalyze growth in sales.

On the flipside, the market for computed tomography (CT) is being challenged by the stringent regulatory polices pertaining to healthcare devices and the also the strict approval process for new products. Inadequate reimbursement policies is serving to clip market growth to an extent as well.

More Trending Reports by Transparency Market Research –

Porcine Vaccines Market: prnewswire.com/news-releases/porcine-vaccines-market-to-reach-us-3208-mn-by-2025-says-tmr-679503443.html

Medical Imaging Phantoms Market: prnewswire.com/news-releases/medical-imaging-phantoms-market-to-attain-a-value-of-us180-0-million-by-2026—says-tmr-300832758.html

0 votes

Umbilical cord blood has become a valuable commodity in the healthcare sector in recent years due to rising awareness about the utility of stem cells in the treatment of a wide variety of diseases. Umbilical cord blood is the blood left over in the placenta after childbirth, and is the best source of stem cells. Stem cells have become vital in the medical field due to their capacity to regenerate into any kind of human cells. This has made them a prime candidate for the treatment of several degenerative diseases that have proven to be beyond mankind so far. Genetic and hematopoietic diseases are also treated with stem cells, further increasing the utility of the umbilical cord blood market to the healthcare sector.

Report overview @ https://www.transparencymarketresearch.com/stem-cell-umbilical-cord-blood-market.html

Growing government support has been crucial for the global umbilical cord blood market and is likely to remain the key driver in the coming years. Safe and convenient storage of umbilical cord blood and stem cells requires sophisticated infrastructure, which requires significant government backing in terms of both economic freedom and regulations. The increasing number of governments acknowledging the utility of stem cells and thus umbilical cord blood to the medical sector is thus crucial for the global umbilical cord blood market.

Government support has also helped the umbilical cord blood overcome social reservations about the use of stem cells. The intimate nature of umbilical cord blood and the strong emotional ties attached to the childbirth process had made obtaining umbilical cord blood difficult due to lack of popular support. Steady government presence in awareness programs has thus proved important for the umbilical cord blood market. The rising presence of private players in stem cell research is also vital for the global umbilical cord blood market.

Stem Cell Umbilical Cord Blood Market: Overview

Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10547

The cord blood collected during childbirth is cryopreserved and stored. UCB stem cells are stored either at private cord banks or at public cord blood banks. This preserved blood is generally used at the time of treatment of chronic ailments or transplantation, if needed, in the later stages of life.

Governments around the world have been proactively financing campaigns to spread public awareness about the potential benefits of UCB stem cells. This has been a crucial factor boosting the global stem cell umbilical cord blood market in the last few years. Furthermore, such steps taken by governments also provides  economic and social benefits.

The report covers the various factors influencing the growth exhibited by the stem cell umbilical cord blood market. It features an in-depth analysis of the key market drivers, restraints, and opportunities. Other highlights of the report include a market attractiveness analysis, representation of prominent enterprises in the market in terms of key shares, competitive analysis, SWOT analysis, and Porter’s five forces analysis.

Stem Cell Umbilical Cord Blood Market: Key Trends and Opportunities

UCB stem cells have emerged as an effective treatment option for over 80 diseases including immunodeficiency disorders, cancer, and other chronic blood disorders. Many of these diseases have no cure but can be treated effectively using stem cells obtained from the umbilical cord. UCB stem cells travel to the location of the damage, identify the infected cells, and then initiate a healing process. Moreover, the risk of rejection is nonexistent, because they are obtained from the same individual.

With research being underway for developing UCB stem cells to effectively treat diseases such as Alzheimer’s, diabetes, heart failure, and brain tumor, the future of the global stem cell umbilical cord blood market seems very impressive. Owing to their inherent health benefits, UCB stem cells are identified as a successful mode of treatment for various life-threatening ailments.

Pre Book Stem Cell Umbilical Cord Blood Market Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=10547&ltype=S

Government authorities are also supporting clinical trials and research into cord blood stem cells, which has been a crucial factor increasing the interest of the healthcare industry and compelling major healthcare players to invest in the commercialization of UCB stem cells therapies. For instance, Cytori Therapeutics Inc., Athersys, and California Stem Cell Inc. are engaged in developing novel stem cell therapies from UCB stem cells. This is a key factor offering impetus to the global market for stem cell umbilical cord blood.

Stem Cell Umbilical Cord Blood Market: Competitive Outlook

Competition prevailing in the global stem cell umbilical cord blood market is currently intense, with enterprises focusing mainly on creating brand awareness. This is compelling enterprises operating in the market to formulate innovative strategies. To study the competition prevailing in the market, the report profiles companies such as Nuo Therapeutics, Teva Pharmaceuticals, Cytori Therapeutics, and others.

These companies are studied on the basis of their financial overview, business structure, supply chain network, strategies adopted, and current development status.

More Trending Reports by Transparency Market Research –

Shock Wave Therapy Device Market: prnewswire.com/news-releases/shock-wave-therapy-device-market-to-reach-us-1399-mn-by-2025-orthopedic-and-urology-application-leads-the-market-677627753.html

Life Sciences BPO Market: prnewswire.com/news-releases/life-sciences-bpo-market-is-expected-to-touch-us286-3-billion-by-2023—says-tmr-300813081.html

0 votes

According to Transparency Market Research (TMR), the Asia, Europe, and South America anti-aging market have a highly competitive landscape. Some of the key players operating in the In order to remain dominant in the market, these players are focusing on the new product innovation and launching cost-effective products.

According to a report by Transparency Market Research (TMR), the Asia, Europe, and South America anti-aging market is expected to expand with a CAGR of 9.30% from 2014 to 2020, to attain the value of US$30.9 bn by the end of 2020 from US$15.3 bn in the year 2012. In 2013, the anti-wrinkle product segment accounted for the larger share in anti-aging market presence in Asia. The anti-wrinkle product segment gained more than US$8.1 bn in Asia in 2013. Among these regions, Europe accounted for the larger share in 2013, with increasing demand for hair restoration treatments.

Planning To Lay Down Future Strategy? Request Brochure Of Asia, Europe and South America Anti Aging Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5021

Increasing Number of Personal Aesthetics to Fuel Adoption  

Signs of aging such as appearance of dark spots on skin, dullness, lines & wrinkles, sagging skin, and patchy skin. Along with increasing geriatric population globally is boosting adoption of anti-aging products which is likely to drive the growth of the anti-aging market.  Developing products that promise restoration of youthful skin and reversal of signs of aging have been the biggest motivating factor cosmetologists and healthcare professionals in the anti-aging market. This task is leading to huge investments in the research and development (R&D) activities from numerous companies. Development of comparatively affordable services and devices is augmenting the growth of the anti-aging market presence in Asia, Europe, and South America regions.

The number of personal aesthetics is increasing as well as the rising desire of looking good is augmenting adoption of the anti-aging products. This high adoption is bolstering the growth of the anti-aging market presence in Asia, Europe, and South America regions. Additionally, raising awareness about the presence of numerous treatments and anti-aging products is boosting demand for anti-aging market.

To Obtain All-Inclusive Information On Forecast Analysis Of Asia, Europe and South America Anti Aging Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=5021

Technological Advancements to Create Opportunities

Despite these growth prospects, the skepticism described by other consumers are restraining growth of the anti-aging market. In addition, increasing consumer preference for natural and organic products over cosmetics which contain chemicals is hampering growth of the market. Nevertheless, technological advancements in the products and some of the stringent regulations have helped to regain the trust and belief of their consumers. This developed trust is leading to create lucrative opportunities for growth of the market. Additionally, launch of new and advanced products are expected to augment growth of the anti-aging market.

...